Literature DB >> 28405898

Current Smokers' Preferences for Receiving Cessation Information in a Lung Cancer Screening Setting.

Lisa Carter-Harris1, Rhonda Schwindt2, Giorgos Bakoyannis3, DuyKhanh Pham Ceppa4, Susan M Rawl5.   

Abstract

The purpose of this study was to identify current smokers' communication format preferences for receiving smoking cessation information in a lung cancer screening setting. A cross-sectional correlational design using survey methodology with 159 screening-eligible current smokers was the method used. Data was dichotomized (digital versus traditional preference) and analyzed using Pearson's chi-squared test, Mann-Whitney U test, and logistic regression. Race was a statistically significant predictor with White participants having four times greater odds of reporting preference for a digital format for receiving smoking cessation information such as social media and/or supportive text messages (OR: 4.06; p = 0.004). Lung cancer screening is a new venue where current long-term smokers can be offered information about smoking cessation while they are engaging in a health-promoting behavior and potentially more likely to contemplate quitting. It is important to consider the communication format preference of current smokers to support cessation uptake. This study is the first to examine communication format preference of current smokers in the context of the lung cancer screening venue. Key differences noted by race support the need for further research examining multiple formats of communication with efforts to maximize options in the cancer screening setting.

Entities:  

Keywords:  Health communication; Lung cancer screening; Smoking cessation

Mesh:

Year:  2018        PMID: 28405898      PMCID: PMC5638665          DOI: 10.1007/s13187-017-1222-7

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  26 in total

1.  The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial.

Authors:  Carlijn M van der Aalst; Harry J de Koning; Karien A M van den Bergh; Marc C Willemsen; Rob J van Klaveren
Journal:  Lung Cancer       Date:  2011-11-04       Impact factor: 5.705

2.  A randomised control study of a fully automated internet based smoking cessation programme.

Authors:  L H G Swartz; J W Noell; S W Schroeder; D V Ary
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

Review 3.  Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.

Authors:  Lisa M Fucito; Sharon Czabafy; Peter S Hendricks; Chris Kotsen; Donna Richardson; Benjamin A Toll
Journal:  Cancer       Date:  2016-02-24       Impact factor: 6.860

4.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

Review 5.  American Cancer Society lung cancer screening guidelines.

Authors:  Richard Wender; Elizabeth T H Fontham; Ermilo Barrera; Graham A Colditz; Timothy R Church; David S Ettinger; Ruth Etzioni; Christopher R Flowers; G Scott Gazelle; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Daniel C Sullivan; William Travis; Louise Walter; Andrew M D Wolf; Otis W Brawley; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2013-01-11       Impact factor: 508.702

6.  Incorporating a Smoking Cessation Intervention into Lung Cancer Screening Programs: Preliminary Studies.

Authors:  Charlotte J Hagerman; Catherine A Tomko; Cassandra A Stanton; Jenna A Kramer; David B Abrams; Eric D Anderson; Kathryn L Taylor
Journal:  J Psychosoc Oncol       Date:  2015

7.  Happy ending: a randomized controlled trial of a digital multi-media smoking cessation intervention.

Authors:  Håvar Brendryen; Pål Kraft
Journal:  Addiction       Date:  2008-03       Impact factor: 6.526

8.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

9.  Preferences for the Provision of Smoking Cessation Education Among Cancer Patients.

Authors:  Lorna Sampson; Janet Papadakos; Victoria Milne; Lisa W Le; Geoffrey Liu; Nazek Abdelmutti; Robin Milne; David P Goldstein; Lawson Eng; Meredith Giuliani
Journal:  J Cancer Educ       Date:  2018-02       Impact factor: 2.037

10.  Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial.

Authors:  Caroline Free; Rosemary Knight; Steven Robertson; Robyn Whittaker; Phil Edwards; Weiwei Zhou; Anthony Rodgers; John Cairns; Michael G Kenward; Ian Roberts
Journal:  Lancet       Date:  2011-07-02       Impact factor: 79.321

View more
  3 in total

1.  Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review.

Authors:  Ernesto Sosa; Gail D'Souza; Aamna Akhtar; Melissa Sur; Kyra Love; Jeanette Duffels; Dan J Raz; Jae Y Kim; Virginia Sun; Loretta Erhunmwunsee
Journal:  CA Cancer J Clin       Date:  2021-05-20       Impact factor: 286.130

2.  Using social media for health research: Methodological and ethical considerations for recruitment and intervention delivery.

Authors:  Danielle Arigo; Sherry Pagoto; Lisa Carter-Harris; Sarah E Lillie; Camille Nebeker
Journal:  Digit Health       Date:  2018-05-07

3.  Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend.

Authors:  Samantha Groves; Grace McCutchan; Samantha L Quaife; Rachael L Murray; Jamie S Ostroff; Kate Brain; Philip A J Crosbie; Janelle Yorke; David Baldwin; John K Field; Lorna McWilliams
Journal:  Health Expect       Date:  2022-05-05       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.